Cypress Capital Management (Delaware)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $281K | Hold |
|
|||||
|
2022
Q2 | $304K | Sell |
|
|||||
|
2022
Q1 | $292K | Sell |
|
|||||
|
2021
Q4 | $299K | Sell |
|
|||||
|
2021
Q3 | $324K | Hold |
|
|||||
|
2021
Q2 | $324K | Hold |
|
|||||
|
2021
Q1 | $306K | Sell |
|
|||||
|
2020
Q4 | $353K | Sell |
|
|||||
|
2020
Q3 | $437K | Hold |
|
|||||
|
2020
Q2 | $426K | Sell |
|
|||||
|
2020
Q1 | $414K | Hold |
|
|||||
|
2019
Q4 | $477K | Sell |
|
|||||
|
2019
Q3 | $9.17M | Buy |
|
|||||
|
2019
Q2 | $7M | Buy |
|
|||||
|
2019
Q1 | $6.08M | Buy |
|
|||||
|
2018
Q4 | $5.97M | Buy |
|
|||||
|
2018
Q3 | $407K | Buy |
|
|||||
|
2018
Q2 | $357K | Hold |
|
|||||
|
2018
Q1 | $408K | Hold |
|
|||||
|
2017
Q4 | $395K | Sell |
|
|||||
|
2017
Q3 | $424K | Hold |
|
|||||
|
2017
Q2 | $371K | Buy |
|